SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-16-018778
Filing Date
2016-11-21
Accepted
2016-11-21 11:17:25
Documents
6
Period of Report
2016-12-06
Effectiveness Date
2016-11-21

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A def14a111816_dandritbiotech.htm DEF 14A 478915
2 GRAPHIC image_001.jpg GRAPHIC 1112
3 GRAPHIC image_002.jpg GRAPHIC 1115
4 GRAPHIC image_003.jpg GRAPHIC 9957
5 GRAPHIC image_004.jpg GRAPHIC 6684
6 GRAPHIC image_005.jpg GRAPHIC 11783
  Complete submission text file 0001213900-16-018778.txt   523002
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-54478 | Film No.: 162009462
SIC: 2834 Pharmaceutical Preparations